CorMedix stockholders elect directors and approve all four proposals at 2022 annual meeting

CorMedix Inc.

Seven director nominees elected (Costa, Dillione, Duncan, Dunton, Kaplan, Lefkowitz, Todisco) with for votes ranging from 7.6M to 9.2M; 19.1M broker non-votes.
Advisory vote on executive compensation approved: 8,041,682 for, 2,406,462 against, 123,127 abstain.
Amendment and restatement of 2019 Omnibus Stock Incentive Plan approved: 8,110,236 for, 2,308,931 against.
Ratification of Friedman LLP as independent auditor for FY2022 approved: 27,961,029 for, 1,579,888 against.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.